News-Medical.Net on MSN
Study analyzes alterations in the cerebral cortex in people with psychosis
Researchers at the University of Seville have analyzed alterations in the cerebral cortex in people suffering from psychosis.
Morning Overview on MSN
How science and luck sparked a radical new era in schizophrenia treatment
The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...
Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond pivotal 12-week results, supporting development of evenamide as the potential first add-on therapy for ...
Newron secures up to EUR 38 million to advance its ENIGMA-TRS pivotal phase III programme: Milan, Italy Wednesday, February 18, 2026, 18:00 Hrs [IST] Newron Pharmaceuticals SpA, a ...
However, the opioid pathway, a heavily studied physiologic pathway inextricably intertwined with behaviour and reward, rarely receives attention within psychiatric practice. Although the opioid system ...
Researchers at the University of Seville have analyzed alterations in the cerebral cortex in people suffering from psychosis. Their findings show that psychosis does not follow a single trajectory, ...
Vanda Pharmaceuticals had 9% revenue growth and heavy losses with a 1.4x sales valuation and a PDUFA date. Check out why VNDA stock is downgraded to hold.
By Sneha S K and Kunal Das Feb 20 (Reuters) - The U.S. Food and Drug Administration has approved Vanda Pharmaceuticals' drug for the treatment of two serious mental health conditions, the company said ...
Other cells, such as glial cells, support the function of neurons. Neuroscience has often painted glial cells as the glue ...
The brain not only communicates through fast electrical impulses, it also relies on slower, more diffuse chemical signals that modulate our emotional and social states over time. A study led by the ...
Dimethyltryptamine’s short duration of psychedelic effects makes it a potentially practical alternative to other ...
The team of researchers led by Prof. Kristian Franze found that increasing tissue stiffness induces the expression of chemical signals that are typically absent in those regions. Semaphorin 3A is one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results